Porcine model of neurocysticercosis by intracarotid injection of Taenia solium oncospheres: Dose assessment, infection outcomes and serological responses.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
12
01
2022
accepted:
26
04
2022
entrez:
2
6
2022
pubmed:
3
6
2022
medline:
7
6
2022
Statut:
epublish
Résumé
Neurocysticercosis (NCC) is the infection of the human central nervous system (CNS) by Taenia solium larvae that cause significant neurological morbidity. Studies on NCC pathophysiology, host-parasite interactions or therapeutic agents are limited by the lack of suitable animal models. We have previously reported that carotid injection of activated T. solium oncospheres directs parasites into the CNS and consistently reproduces NCC. This study assessed the minimal dose required to consistently obtain NCC by intracarotid oncosphere injection and compared antigen and antibody response profiles by dose-group. Three groups of pigs were infected with either 2500 (n = 10), 5000 (n = 11), or 10000 (n = 10) oncospheres. Two pigs died during the study. Necropsy exam at day 150 post-infection (PI) demonstrated viable NCC in 21/29 pigs (72.4%), with higher NCC rates with increasing oncosphere doses (4/9 [44.4%], 9/11 [81.8%] and 8/9 [88.9%] for 2500, 5000, and 10000 oncospheres respectively, P for trend = 0.035). CNS cyst burden was also higher in pigs with increasing doses (P for trend = 0.008). Viable and degenerated muscle cysticerci were also found in all pigs, with degenerated cysticerci more frequent in the 2500 oncosphere dose-group. All pigs were positive for circulating parasite antigens on ELISA (Ag-ELISA) from day 14 PI; circulating antigens markedly increased at day 30 PI and remained high with plateau levels in pigs infected with either 5000 or 10000 oncospheres, but not in pigs infected with 2500 oncospheres. Specific antibodies appeared at day 30 PI and were not different between dose-groups. Intracarotid injection of 5000 or more oncospheres produces high NCC rates in pigs with CNS cyst burdens like those usually found in human NCC, making this model appropriate for studies on the pathogenesis of NCC and the effects of antiparasitic treatment.
Sections du résumé
BACKGROUND
Neurocysticercosis (NCC) is the infection of the human central nervous system (CNS) by Taenia solium larvae that cause significant neurological morbidity. Studies on NCC pathophysiology, host-parasite interactions or therapeutic agents are limited by the lack of suitable animal models. We have previously reported that carotid injection of activated T. solium oncospheres directs parasites into the CNS and consistently reproduces NCC. This study assessed the minimal dose required to consistently obtain NCC by intracarotid oncosphere injection and compared antigen and antibody response profiles by dose-group.
METHODS/PRINCIPAL FINDINGS
Three groups of pigs were infected with either 2500 (n = 10), 5000 (n = 11), or 10000 (n = 10) oncospheres. Two pigs died during the study. Necropsy exam at day 150 post-infection (PI) demonstrated viable NCC in 21/29 pigs (72.4%), with higher NCC rates with increasing oncosphere doses (4/9 [44.4%], 9/11 [81.8%] and 8/9 [88.9%] for 2500, 5000, and 10000 oncospheres respectively, P for trend = 0.035). CNS cyst burden was also higher in pigs with increasing doses (P for trend = 0.008). Viable and degenerated muscle cysticerci were also found in all pigs, with degenerated cysticerci more frequent in the 2500 oncosphere dose-group. All pigs were positive for circulating parasite antigens on ELISA (Ag-ELISA) from day 14 PI; circulating antigens markedly increased at day 30 PI and remained high with plateau levels in pigs infected with either 5000 or 10000 oncospheres, but not in pigs infected with 2500 oncospheres. Specific antibodies appeared at day 30 PI and were not different between dose-groups.
CONCLUSION/SIGNIFICANCE
Intracarotid injection of 5000 or more oncospheres produces high NCC rates in pigs with CNS cyst burdens like those usually found in human NCC, making this model appropriate for studies on the pathogenesis of NCC and the effects of antiparasitic treatment.
Identifiants
pubmed: 35653367
doi: 10.1371/journal.pntd.0010449
pii: PNTD-D-22-00064
pmc: PMC9162370
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010449Subventions
Organisme : FIC NIH HHS
ID : D43 TW001140
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143553
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI129909
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Trop Med Hyg. 1994 Dec;51(6):847-50
pubmed: 7810821
Mol Biochem Parasitol. 2007 Mar;152(1):90-100
pubmed: 17210192
Clin Infect Dis. 2018 Jan 6;66(2):282-288
pubmed: 29020381
Vet Immunol Immunopathol. 1991 Aug;29(1-2):69-78
pubmed: 1949584
Int J Parasitol. 2008 Aug;38(10):1191-8
pubmed: 18328486
J Immunol. 1999 Jan 15;162(2):995-1002
pubmed: 9916725
PLoS Negl Trop Dis. 2012;6(5):e1500
pubmed: 22666505
PLoS Negl Trop Dis. 2015 Dec 11;9(12):e0004207
pubmed: 26658257
Clin Infect Dis. 2013 Oct;57(7):e154-9
pubmed: 23788241
Indian J Med Res. 2016 Sep;144(3):319-326
pubmed: 28139530
Vet Parasitol. 2003 Feb 27;111(4):323-32
pubmed: 12559711
PLoS Negl Trop Dis. 2017 Mar 7;11(3):e0005153
pubmed: 28267746
Acta Trop. 2017 Jan;165:161-169
pubmed: 26802489
Am J Trop Med Hyg. 2018 Aug;99(2):380-387
pubmed: 29893202
Acta Trop. 2017 Feb;166:218-224
pubmed: 27880878
Trends Parasitol. 2017 Jan;33(1):65-73
pubmed: 27720140
Am J Trop Med Hyg. 2011 Sep;85(3):460-3
pubmed: 21896805
Rev Bras Parasitol Vet. 2014 Mar;23(1):94-7
pubmed: 24728368
J Parasitol. 2002 Feb;88(1):69-73
pubmed: 12053982
Infect Immun. 2007 Nov;75(11):5158-66
pubmed: 17698575
PLoS Negl Trop Dis. 2016 Feb 10;10(2):e0004396
pubmed: 26863440
Curr Trop Med Rep. 2014 Dec 1;1(4):181-193
pubmed: 25544938
Am J Pathol. 2015 Aug;185(8):2259-68
pubmed: 26216286
Am J Trop Med Hyg. 1994 Jan;50(1):33-44
pubmed: 7905720
Parasitol Res. 1990;76(3):263-9
pubmed: 2315286
Exp Parasitol. 2016 Jul;166:37-43
pubmed: 27018063
Am J Trop Med Hyg. 2015 Dec;93(6):1305-10
pubmed: 26392159
Parasitology. 2016 Mar;143(3):334-42
pubmed: 26626017
Clin Microbiol Rev. 2020 May 27;33(3):
pubmed: 32461308
Lab Anim. 2018 Feb;52(1):88-92
pubmed: 28708034
J Neurol Sci. 2017 Jan 15;372:202-210
pubmed: 28017213
Vet Parasitol. 1996 Jan;61(1-2):49-59
pubmed: 8750683
Vet Parasitol. 2000 Dec 20;94(1-2):33-44
pubmed: 11078942
Lancet Neurol. 2014 Dec;13(12):1202-15
pubmed: 25453460
PLoS Negl Trop Dis. 2014 Sep 11;8(9):e3125
pubmed: 25210748
Am J Trop Med Hyg. 1990 Aug;43(2):194-9
pubmed: 2389823
Am J Trop Med Hyg. 2014 Feb;90(2):318-21
pubmed: 24394477
Parasite Immunol. 2017 Jul;39(7):
pubmed: 28467600
J Parasitol. 2006 Aug;92(4):738-41
pubmed: 16995390
Parasit Vectors. 2017 Nov 16;10(1):572
pubmed: 29145875
Lancet. 2004 Mar 20;363(9413):949-50
pubmed: 15043964
Am J Trop Med Hyg. 2018 Nov;99(5):1198-1200
pubmed: 30203742
J Cereb Blood Flow Metab. 2013 Jan;33(1):13-21
pubmed: 23072749
Parasitology. 2010 Mar;137(3):359-72
pubmed: 20109250
Parasitology. 2019 Apr;146(5):553-562
pubmed: 30430955
J Magn Reson Imaging. 2004 Aug;20(2):208-15
pubmed: 15269945
Epilepsia. 2015 Feb;56(2):177-83
pubmed: 25534640
J Infect Dis. 2009 May 1;199(9):1345-52
pubmed: 19358669
J Clin Microbiol. 2018 Aug 27;56(9):
pubmed: 29875195
J Comp Pathol. 2002 Aug-Oct;127(2-3):186-93
pubmed: 12354530
Parasitol Int. 2006 Jun;55(2):151-4
pubmed: 16516537
PLoS Negl Trop Dis. 2017 Jun 2;11(6):e0005624
pubmed: 28575043
PLoS Negl Trop Dis. 2015 Aug 07;9(8):e0003980
pubmed: 26252878
Parasitol Int. 2006;55 Suppl:S131-5
pubmed: 16352459